Citigroup
BBC icon

Citigroup’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Citigroup’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$46 Buy
+1
New +$51 ﹤0.01% 5720

Other funds holding BBC

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Dynamic Wealth Strategies
Dynamic Wealth Strategies Granite Bay, California $188M AUM 12.25% 1-Year Est. Return
Compass Financial Management
Compass Financial Management Tampa, Florida $926M AUM
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Citigroup's BBC Position: Q3 2026 in Review

Citigroup opened a new position in Virtus Biotech Clinical Trials ETF (BBC) in Q3 2026: 1 share worth $46. The stake represents ﹤0.01% of the portfolio and ranks #5720 among its holdings.

7 funds tracked by Wall St. Rank hold BBC as of Q3 2026.

  • Citigroup held 1 share of Virtus Biotech Clinical Trials ETF worth $46 as of Q3 2026.
  • Virtus Biotech Clinical Trials ETF was a new Citigroup position in Q3 2026.
  • Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5720 holding.
  • 7 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.